The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1977, 118: 302-308.
Copyright © 1977 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dosch, H.-M.
Right arrow Articles by Gelfand, E. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dosch, H.-M.
Right arrow Articles by Gelfand, E. W.

Generation of Human Plaque-Forming Cells in Culture: Tissue Distribution, Antigenic and Cellular Requirements1

Hans-Michael Dosch2 and Erwin W. Gelfand3

From the Research Institute, Department of Immunology, The Hospital For Sick Children, Toronto, Ontario, Canada, M5G 1X8

Abstract

A system for the induction of specific, hemolytic plaque-forming cells from normal human lymphocytes in vitro (HcPFC) has been established and cells from various normal lymphoid tissues have been investigated. Normal values for anti-SRBC HcPFC responses in cultures of 107 Ficoll-Hypaque separated lymphocytes range from 2000 (bone marrow) to 7000 (spleen) and 15,000 (tonsillar and peripheral blood lymphocytes). HcPFC responses to ovalbumin were lower by a factor of 2 to 4. Anti-SRBC as well as anti-ovalbumin responses required the cooperation of T lymphocytes and IgM-bearing B lymphocytes and the magnitude of the response was antigen dose dependent. Addition of adherent cells as well as of 2-mercaptoethanol enhanced the response. On the basis of the data obtained in experiments examining the role of B and T lymphocytes, a tentative model of cellular interaction has been postulated, suggesting a major role for antigen concentration in the modulation of the response via reactive T lymphocytes.

Footnotes

1 This work was supported by a Grant MA 4875 from the Medical Research Council of Canada.

2 Dr. Dosch is a fellow of the Deutsche Forschungsgemeinschaft.

3 Dr. Gelfand is recipient of a Queen Elizabeth II Scientist Award. Please send correspondence to: Dr. E. W. Gelfand, Department of Immunology, The Hospital For Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G 1X8.




This article has been cited by other articles:


Home page
ScienceHome page
E. Gelfand, H. Dosch, B Hastings, and A Shore
Lithium: a modulator of cyclic AMP-dependent events in lymphocytes?
Science, January 26, 1979; 203(4378): 365 - 367.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1977 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1977 by The American Association of Immunologists, Inc. All rights reserved.